{"transactions":[{"id":682668,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-18T21:04:35.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":false,"shares":6623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to continuous service, the RSUs under the award will vest in three substantially equal installments, with one-third of the RSUs vesting on the first Company quarterly vesting date to occur\nafter each of the first, second, and third anniversaries of the director's service commencement date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to continuous service, the RSUs under the award will vest in three substantially equal installments, with one-third of the RSUs vesting on the first Company quarterly vesting date to occur\nafter each of the first, second, and third anniversaries of the director's service commencement date."}],"balance_after":6624,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6623},"source":{"system":"sec-edgar","filing":"0001773751-26-000214","document":"wk-form4_1787087073.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375126000214/wk-form4_1787087073.xml","form_type":"4"}},{"id":682667,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-18T21:04:35.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":true,"shares":6623,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU."}],"balance_after":26020,"source":{"system":"sec-edgar","filing":"0001773751-26-000214","document":"wk-form4_1787087073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375126000214/wk-form4_1787087073.xml","form_type":"4"}},{"id":686445,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-14T20:16:10.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":8223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units (\"RSUs\") represent a contingent right to receive one share of Class A Common Stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award."}],"balance_after":8223,"derivative":{"underlying":"Class A Common Stock","underlying_shares":8223},"source":{"system":"sec-edgar","filing":"0001773751-26-000192","document":"wk-form4_1786738568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375126000192/wk-form4_1786738568.xml","form_type":"4"}},{"id":737375,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-15T21:13:39.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":3656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3656},"source":{"system":"sec-edgar","filing":"0001773751-26-000115","document":"wk-form4_1781558016.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375126000115/wk-form4_1781558016.xml","form_type":"4"}},{"id":737374,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-15T21:13:39.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":3656,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026."}],"balance_after":19397,"source":{"system":"sec-edgar","filing":"0001773751-26-000115","document":"wk-form4_1781558016.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375126000115/wk-form4_1781558016.xml","form_type":"4"}},{"id":1037058,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-09-17T23:24:32.000Z","date":"2025-09-15","kind":"exercise","planned":false,"acquired":false,"shares":6623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units (\"RSUs\") represent a contingent right to receive one share of Class A Common Stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with (i) 1/3 of the RSUs vesting on September 15, 2025, (ii) 1/3 of the RSUs vesting on September 15, 2026, and (iii) 1/3 of the RSUs vesting on September 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with (i) 1/3 of the RSUs vesting on September 15, 2025, (ii) 1/3 of the RSUs vesting on September 15, 2026, and (iii) 1/3 of the RSUs vesting on September 15, 2027."}],"balance_after":13247,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6623},"source":{"system":"sec-edgar","filing":"0001773751-25-000299","document":"wk-form4_1758151469.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375125000299/wk-form4_1758151469.xml","form_type":"4"}},{"id":1037057,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-17T23:24:32.000Z","date":"2025-09-15","kind":"exercise","planned":false,"acquired":true,"shares":6623,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Restricted Stock Units (\"RSUs\") represent a contingent right to receive one share of Class A Common Stock for each RSU."}],"balance_after":15741,"source":{"system":"sec-edgar","filing":"0001773751-25-000299","document":"wk-form4_1758151469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375125000299/wk-form4_1758151469.xml","form_type":"4"}},{"id":1071054,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:19:22.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":3656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026."}],"balance_after":3656,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3656},"source":{"system":"sec-edgar","filing":"0001773751-25-000264","document":"wk-form4_1754684359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375125000264/wk-form4_1754684359.xml","form_type":"4"}},{"id":1109383,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-17T00:38:13.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":false,"shares":9118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9118},"source":{"system":"sec-edgar","filing":"0001773751-25-000201","document":"wk-form4_1750120687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375125000201/wk-form4_1750120687.xml","form_type":"4"}},{"id":1109382,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-17T00:38:13.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":true,"shares":9118,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025."}],"balance_after":9118,"source":{"system":"sec-edgar","filing":"0001773751-25-000201","document":"wk-form4_1750120687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375125000201/wk-form4_1750120687.xml","form_type":"4"}},{"id":1437653,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-08-08T20:25:13.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":9118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person was granted Restricted Stock Units (\"RSUs\") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025."}],"balance_after":9118,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9118},"source":{"system":"sec-edgar","filing":"0001773751-24-000270","document":"wk-form4_1723148701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375124000270/wk-form4_1723148701.xml","form_type":"4"}},{"id":1437652,"issuer":{"id":1878,"kind":"organization","name":"Hims & Hers Health, Inc.","symbol":"HIMS"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-08-08T20:25:13.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":19870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units (\"RSUs\") represent a contingent right to receive one share of Class A Common Stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with (i) 1/3 of the RSUs vesting on September 15, 2025, (ii) 1/3 of the RSUs vesting on September 15, 2026, and (iii) 1/3 of the RSUs vesting on September 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with (i) 1/3 of the RSUs vesting on September 15, 2025, (ii) 1/3 of the RSUs vesting on September 15, 2026, and (iii) 1/3 of the RSUs vesting on September 15, 2027."}],"balance_after":19870,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19870},"source":{"system":"sec-edgar","filing":"0001773751-24-000270","document":"wk-form4_1723148701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724567/000177375124000270/wk-form4_1723148701.xml","form_type":"4"}},{"id":2127794,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2022-11-02T12:55:01.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":116389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on November 3, 2017 with 63,613 vested on November 3, 2019, 180,000 vested on each of November 1, 2020 and November 1, 2021 and 116,389 vested on November 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on November 3, 2017 with 63,613 vested on November 3, 2019, 180,000 vested on each of November 1, 2020 and November 1, 2021 and 116,389 vested on November 1, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":116389},"source":{"system":"sec-edgar","filing":"0001209191-22-055177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122055177/doc4.xml","form_type":"4"}},{"id":2127793,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-11-02T12:55:01.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":116389,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":1542471,"source":{"system":"sec-edgar","filing":"0001209191-22-055177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122055177/doc4.xml","form_type":"4"}},{"id":2280261,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-06T22:04:09.000Z","date":"2022-05-05","kind":"exercise","acquired":false,"shares":1089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The RSUs convert to Common Stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of Restricted Stock Units (\"RSUs\") on May 5, 2022, the reporting person did not defer the receipt of 1,089 shares of Common Stock pursuant to IFF's deferred compensation plan."}],"balance_after":0,"derivative":{"exercise_date":"2022-05-05","expiration_date":"2022-05-05","underlying":"Common Stock","underlying_shares":1089},"source":{"system":"sec-edgar","filing":"0001225208-22-006660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520822006660/doc4.xml","form_type":"4"}},{"id":2280260,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-06T22:04:09.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":1245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The RSUs convert to Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represent RSUs granted under the Non-Employee Director Compensation Program."}],"balance_after":1245,"derivative":{"exercise_date":"2023-05-04","expiration_date":"2023-05-04","underlying":"Common Stock","underlying_shares":1245},"source":{"system":"sec-edgar","filing":"0001225208-22-006660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520822006660/doc4.xml","form_type":"4"}},{"id":2280259,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-06T22:04:09.000Z","date":"2022-05-05","kind":"exercise","acquired":true,"shares":1089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of Restricted Stock Units (\"RSUs\") on May 5, 2022, the reporting person did not defer the receipt of 1,089 shares of Common Stock pursuant to IFF's deferred compensation plan."}],"balance_after":1344,"source":{"system":"sec-edgar","filing":"0001225208-22-006660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520822006660/doc4.xml","form_type":"4"}},{"id":2345938,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:12:08.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":71292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 71,292 having vested on March 5, 2022, 71,292 vesting on each of March 5, 2023 and March 5, 2024, and 71,295 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 71,292 having vested on March 5, 2022, 71,292 vesting on each of March 5, 2023 and March 5, 2024, and 71,295 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":213879,"derivative":{"underlying":"Ordinary Shares","underlying_shares":71292},"source":{"system":"sec-edgar","filing":"0001209191-22-017058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017058/doc4.xml","form_type":"4"}},{"id":2345937,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:12:08.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":402144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 100,536 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 100,536 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":402144,"derivative":{"underlying":"Ordinary Shares","underlying_shares":402144},"source":{"system":"sec-edgar","filing":"0001209191-22-017058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017058/doc4.xml","form_type":"4"}},{"id":2345936,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:12:08.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":162593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":162593},"source":{"system":"sec-edgar","filing":"0001209191-22-017058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017058/doc4.xml","form_type":"4"}},{"id":2345935,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:12:08.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 4, 2019, with 59,701 having vested on each of March 4, 2021 and March 4, 2022 and 59,702 vesting on\nMarch 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 4, 2019, with 59,701 having vested on each of March 4, 2021 and March 4, 2022 and 59,702 vesting on\nMarch 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":59702,"derivative":{"underlying":"Ordinary Shares","underlying_shares":59701},"source":{"system":"sec-edgar","filing":"0001209191-22-017058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017058/doc4.xml","form_type":"4"}},{"id":2345934,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:12:08.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":71292,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":1426082,"source":{"system":"sec-edgar","filing":"0001209191-22-017058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017058/doc4.xml","form_type":"4"}},{"id":2345933,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:12:08.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":162593,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":1354790,"source":{"system":"sec-edgar","filing":"0001209191-22-017058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017058/doc4.xml","form_type":"4"}},{"id":2345932,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:12:08.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":59701,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":1192197,"source":{"system":"sec-edgar","filing":"0001209191-22-017058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017058/doc4.xml","form_type":"4"}},{"id":2363042,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2022-03-02T12:51:55.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":65047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on February 28, 2020, with 65,047 having vested on each of February 28, 2021 and February 28, 2022,\n65,047 vesting on February 28, 2023 and 65,049 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on February 28, 2020, with 65,047 having vested on each of February 28, 2021 and February 28, 2022,\n65,047 vesting on February 28, 2023 and 65,049 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":130096,"derivative":{"underlying":"Ordinary Shares","underlying_shares":65047},"source":{"system":"sec-edgar","filing":"0001209191-22-014473","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014473/doc4.xml","form_type":"4"}},{"id":2363041,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-03-02T12:51:55.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":65047,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":1132496,"source":{"system":"sec-edgar","filing":"0001209191-22-014473","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014473/doc4.xml","form_type":"4"}},{"id":2405268,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2022-02-10T21:12:22.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":162593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on March 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on March 4, 2022."}],"balance_after":162593,"derivative":{"underlying":"Ordinary Shares","underlying_shares":162593},"source":{"system":"sec-edgar","filing":"0001209191-22-008417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008417/doc4.xml","form_type":"4"}},{"id":2405267,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2022-02-10T21:12:22.000Z","date":"2022-02-09","kind":"exercise","acquired":false,"shares":26867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on February 9, 2018, with 26,867 having vested on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on February 9, 2018, with 26,867 having vested on each of February 9, 2020, February 9, 2021 and February 9, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":26867},"source":{"system":"sec-edgar","filing":"0001209191-22-008417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008417/doc4.xml","form_type":"4"}},{"id":2405266,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-02-10T21:12:22.000Z","date":"2022-02-09","kind":"exercise","acquired":true,"shares":26867,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":1067449,"source":{"system":"sec-edgar","filing":"0001209191-22-008417","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008417/doc4.xml","form_type":"4"}},{"id":2527555,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2021-11-03T11:25:09.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on November 3, 2017, with 63,613 vested on November 3, 2019, 180,000 vested on each of November 1, 2020 and November 1, 2021 and 116,389 vesting on November 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on November 3, 2017, with 63,613 vested on November 3, 2019, 180,000 vested on each of November 1, 2020 and November 1, 2021 and 116,389 vesting on November 1, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":116389,"derivative":{"underlying":"Ordinary Shares","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-21-062591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121062591/doc4.xml","form_type":"4"}},{"id":2527554,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-11-03T11:25:09.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":180000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1040582,"source":{"system":"sec-edgar","filing":"0001209191-21-062591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121062591/doc4.xml","form_type":"4"}},{"id":2724517,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-08T01:45:04.000Z","date":"2021-05-06","kind":"exercise","acquired":false,"shares":255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The RSUs convert to Common Stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of Restricted Stock Units (\"RSUs\") on May 6, 2021, the reporting person did not defer the receipt of 255 shares of Common Stock pursuant to IFF's deferred compensation plan."}],"balance_after":0,"derivative":{"exercise_date":"2021-05-06","expiration_date":"2021-05-06","underlying":"Common Stock","underlying_shares":255},"source":{"system":"sec-edgar","filing":"0001225208-21-007798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520821007798/doc4.xml","form_type":"4"}},{"id":2724516,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-08T01:45:04.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":1089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The RSUs convert to Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represent RSUs granted under the Non-Employee Director Compensation Program."}],"balance_after":1089,"derivative":{"exercise_date":"2022-05-05","expiration_date":"2022-05-05","underlying":"Common Stock","underlying_shares":1089},"source":{"system":"sec-edgar","filing":"0001225208-21-007798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520821007798/doc4.xml","form_type":"4"}},{"id":2724515,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-08T01:45:04.000Z","date":"2021-05-06","kind":"exercise","acquired":true,"shares":255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of Restricted Stock Units (\"RSUs\") on May 6, 2021, the reporting person did not defer the receipt of 255 shares of Common Stock pursuant to IFF's deferred compensation plan."}],"balance_after":255,"source":{"system":"sec-edgar","filing":"0001225208-21-007798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520821007798/doc4.xml","form_type":"4"}},{"id":2804338,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:12:03.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":285171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 5, 2021, with 71,292 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and 71,295 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 5, 2021, with 71,292 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and 71,295 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":285171,"derivative":{"underlying":"Ordinary Shares","underlying_shares":285171},"source":{"system":"sec-edgar","filing":"0001209191-21-018530","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018530/doc4.xml","form_type":"4"}},{"id":2804337,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:12:03.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 4, 2019, with 59,701 vesting on each of March 4, 2021 and March 4, 2022 and 59,702 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 4, 2019, with 59,701 vesting on each of March 4, 2021 and March 4, 2022 and 59,702 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":119403,"derivative":{"underlying":"Ordinary Shares","underlying_shares":59701},"source":{"system":"sec-edgar","filing":"0001209191-21-018530","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018530/doc4.xml","form_type":"4"}},{"id":2804336,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:12:03.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":59701,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":860582,"source":{"system":"sec-edgar","filing":"0001209191-21-018530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018530/doc4.xml","form_type":"4"}},{"id":2817956,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-03-03T22:09:00.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units (\"RSUs\") convert to Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represent RSUs granted under the Non-Employee Director Compensation Program."}],"balance_after":255,"derivative":{"exercise_date":"2021-05-06","expiration_date":"2021-05-06","underlying":"Common Stock","underlying_shares":255},"source":{"system":"sec-edgar","filing":"0001225208-21-004532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520821004532/doc4.xml","form_type":"4"}},{"id":2823352,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2021-03-02T21:09:24.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":65047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on February 28, 2020 with 65,047 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 65,049 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on February 28, 2020 with 65,047 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 65,049 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":195143,"derivative":{"underlying":"Ordinary Shares","underlying_shares":65047},"source":{"system":"sec-edgar","filing":"0001209191-21-015858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015858/doc4.xml","form_type":"4"}},{"id":2823351,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:09:24.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":65047,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":800881,"source":{"system":"sec-edgar","filing":"0001209191-21-015858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121015858/doc4.xml","form_type":"4"}},{"id":2867777,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2021-02-11T21:11:07.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":26867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 9, 2018, with 26,867 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 9, 2018, with 26,867 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":26867,"derivative":{"underlying":"Ordinary Shares","underlying_shares":26867},"source":{"system":"sec-edgar","filing":"0001209191-21-009645","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009645/doc4.xml","form_type":"4"}},{"id":2867776,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:11:07.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":226173,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents ordinary shares received upon satisfaction of performance- and time-based vesting criteria of performance share units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":735834,"source":{"system":"sec-edgar","filing":"0001209191-21-009645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009645/doc4.xml","form_type":"4"}},{"id":2867775,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2021-02-11T21:11:07.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":26867,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":509661,"source":{"system":"sec-edgar","filing":"0001209191-21-009645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121009645/doc4.xml","form_type":"4"}},{"id":2995716,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2020-11-03T12:42:32.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":212314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on February 11, 2020 pursuant to the satisfaction of performance criteria and vested on November 3, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on February 11, 2020 pursuant to the satisfaction of performance criteria and vested on November 3, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":212314},"source":{"system":"sec-edgar","filing":"0001209191-20-056506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120056506/doc4.xml","form_type":"4"}},{"id":2995715,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2020-11-03T12:42:32.000Z","date":"2020-11-01","kind":"exercise","acquired":false,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on November 3, 2017, with 63,613 vesting on November 3, 2019, 180,000 vesting on each of November 1,2020 and November 1, 2021 and 116,389 vesting on November 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on November 3, 2017, with 63,613 vesting on November 3, 2019, 180,000 vesting on each of November 1,2020 and November 1, 2021 and 116,389 vesting on November 1, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":296389,"derivative":{"underlying":"Ordinary Shares","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-20-056506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120056506/doc4.xml","form_type":"4"}},{"id":2995714,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-11-03T12:42:32.000Z","date":"2020-11-03","kind":"exercise","acquired":true,"shares":212314,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":482794,"source":{"system":"sec-edgar","filing":"0001209191-20-056506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120056506/doc4.xml","form_type":"4"}},{"id":2995713,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-11-03T12:42:32.000Z","date":"2020-11-01","kind":"exercise","acquired":true,"shares":180000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":270480,"source":{"system":"sec-edgar","filing":"0001209191-20-056506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120056506/doc4.xml","form_type":"4"}},{"id":3235433,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2020-03-03T12:19:52.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":260190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 65,047 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 65,049 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 65,047 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 65,049 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":260190,"derivative":{"underlying":"Ordinary Shares","underlying_shares":260190},"source":{"system":"sec-edgar","filing":"0001209191-20-014855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120014855/doc4.xml","form_type":"4"}},{"id":3275276,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2020-02-13T12:06:54.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":212314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted shares units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on November 3, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted shares units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on November 3, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":212314,"derivative":{"underlying":"Ordinary Shares","underlying_shares":212314},"source":{"system":"sec-edgar","filing":"0001209191-20-009051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120009051/doc4.xml","form_type":"4"}},{"id":3280667,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2020-02-11T12:04:38.000Z","date":"2020-02-09","kind":"exercise","acquired":false,"shares":26867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on February 9, 2018, with 26,867 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on February 9, 2018, with 26,867 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":53734,"derivative":{"underlying":"Ordinary Shares","underlying_shares":26867},"source":{"system":"sec-edgar","filing":"0001209191-20-008168","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008168/doc4.xml","form_type":"4"}},{"id":3280666,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2020-02-11T12:04:38.000Z","date":"2020-02-09","kind":"exercise","acquired":true,"shares":26867,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":90480,"source":{"system":"sec-edgar","filing":"0001209191-20-008168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919120008168/doc4.xml","form_type":"4"}},{"id":3381042,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2019-11-05T12:19:25.000Z","date":"2019-11-03","kind":"exercise","acquired":false,"shares":63613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on November 3, 2017, with 63,613 vesting on November 3, 2019, 180,000 vesting on each of November 1,\n2020 and November 1, 2021 and 116,389 vesting on November 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on November 3, 2017, with 63,613 vesting on November 3, 2019, 180,000 vesting on each of November 1,\n2020 and November 1, 2021 and 116,389 vesting on November 1, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":476389,"derivative":{"underlying":"Ordinary Shares","underlying_shares":63613},"source":{"system":"sec-edgar","filing":"0001209191-19-055063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119055063/doc4.xml","form_type":"4"}},{"id":3381041,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2019-11-05T12:19:25.000Z","date":"2019-11-03","kind":"exercise","acquired":true,"shares":63613,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":63613,"source":{"system":"sec-edgar","filing":"0001209191-19-055063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119055063/doc4.xml","form_type":"4"}},{"id":3609907,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2019-03-06T12:28:41.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":179104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 59,701 vesting on each of March 4, 2021 and March 4, 2022 and 59,702 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2019, with 59,701 vesting on each of March 4, 2021 and March 4, 2022 and 59,702 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":179104,"derivative":{"underlying":"Ordinary Shares","underlying_shares":179104},"source":{"system":"sec-edgar","filing":"0001209191-19-017236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919119017236/doc4.xml","form_type":"4"}},{"id":4067059,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2018-02-12T21:25:53.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":80601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 26,867 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on February 9, 2018, with 26,867 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":80601,"derivative":{"underlying":"Ordinary Shares","underlying_shares":80601},"source":{"system":"sec-edgar","filing":"0001209191-18-009205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009205/doc4.xml","form_type":"4"}},{"id":4067058,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":22022,"kind":"person","name":"Schultz Kare","position":1,"cik":"0001724567","reported_name":"Schultz Kare","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options (right to buy)","published_at":"2018-02-12T21:25:53.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":205482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options were granted on February 9, 2018, with 68,494 vesting on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":205482,"derivative":{"exercise_price":18.61,"expiration_date":"2028-02-08","underlying":"Ordinary Shares","underlying_shares":205482},"source":{"system":"sec-edgar","filing":"0001209191-18-009205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919118009205/doc4.xml","form_type":"4"}}]}